ArticleDiabetes & metabolic syndrome

Commentary on "angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may be harmful in patients with diabetes during COVID-19 pandemic".

Carlos M FerrarioPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.